Krystal Biotech (KRYS)
NASDAQ:KRYS

Krystal Biotech (KRYS) Financial Statements

427 Followers

Krystal Biotech Financial Overview

Krystal Biotech's market cap is currently ―. The company's EPS TTM is $1.882; its P/E ratio is 111.93; Krystal Biotech is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $0.78. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 45.25M$ 42.14M$ 8.60M--
Gross Profit$ 45.25M$ 39.27M$ 8.60M--
EBIT$ -4.26M$ 113.26M$ 74.50M$ -38.05M$ -48.82M
EBITDA$ -2.66M$ 115.70M$ 75.32M$ -38.05M$ -48.12M
Net Income Common Stockholders$ 932.00K$ 8.69M$ 81.24M$ -33.21M$ -45.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 538.26M$ 532.18M$ 562.07M$ 477.52M$ 350.39M
Total Assets$ 853.30M$ 818.36M$ 790.35M$ 684.03M$ 531.85M
Total Debt$ 7.89M$ 8.09M$ 8.32M$ 8.54M$ 8.76M
Net Debt$ -530.36M$ -524.08M$ -553.75M$ -468.97M$ -341.63M
Total Liabilities$ 54.05M$ 39.71M$ 34.40M$ 30.91M$ 42.28M
Stockholders Equity$ 799.24M$ 778.64M$ 755.95M$ 653.08M$ 489.57M
Cash Flow-
Free Cash Flow$ 14.63M$ -9.08M$ 76.99M$ -33.21M$ -31.54M
Operating Cash Flow$ 15.89M$ -7.23M$ -21.23M$ -33.21M$ -26.16M
Investing Cash Flow$ -25.98M$ -10.16M$ 105.19M-$ 3.56M
Financing Cash Flow$ 10.58M$ 2.62M$ 13.39M-$ 1.47M
Currency in USD

Krystal Biotech Earnings and Revenue History

Krystal Biotech Debt to Assets

Krystal Biotech Cash Flow

Krystal Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis